280+ Launches Later: Two Labs’ Insights on the Commercialization Journey
Today’s drug pipeline is in an interesting spot. In 2022, there were only 44 novel new drugs approved, down from 58 in 2020 and 60
What is Drug Price Transparency?
In 2015, the U.S. government passed the 21st Century Cures Act. In it was a provision called the ‘Open Act,’ designed to increase drug pricing transparency by requiring manufacturers to submit clinical trial results and detailed information on production and
Webinar Recap: The 3 Questions to Consider In Your New Product Launch
If you haven’t had a chance to watch the on-demand webinar, “Top 3 Questions Facing New Launches,” but are curious about where to start with the pharmaceutical commercialization process, we’re giving you a recap of the highlights.
Based on
Public Policy Strategy Helps Realize Clear Access Path for Patients
If you haven’t had a chance to watch the on-demand webinar, “Top 3 Questions Facing New Launches,” but are curious about where to start with the pharmaceutical commercialization process, we’re giving you a recap of the highlights.
Based on
Two Labs’ New Medical Communications Service was Built with Emerging Pharma in Mind
Given the complexities that an emerging manufacturer is managing when developing a new product for launch, it might sound like medical communications is just one more thing on the list. But this couldn’t be further from the truth. This is
Cell & Gene Therapies: How the Industry is Innovating & What Emerging Manufacturers Need to Know
Thousands of rare diseases affect hundreds of millions of people globally, and hope for treatment is on the rise in the form of cell and gene therapies. While only 9 cell and gene therapies are currently FDA-approved in the U.S.,
Case Study: Mock Launch Support
NEED
A pharma client came to Two Labs for patient services mock launch testing prior to their first product commercialization in the U.S. market.
The goal was to ensure successful product launch upon FDA approval, with a well-tested, tightly integrated
Case Study: Post Launch Support
NEED
A biopharma client needed post-launch support for a patient services program for their breakthrough therapy and orphan drug designated immune-oncology product.
Their external patient services model included a designated third-party partner that would handle:
- case management
- reimbursement
- payor-facing activities
Case Study: Post Launch Hub Optimization
… ... Post-Launch Optimization
Whether you’re an emerging manufacturer putting the finishing touches on a new product launch or a small to mid-sized company whose products are outgrowing the post-launch support infrastructure you have in place, Two Labs provides expert consultative services to ensure